Discovery of CDC42 Inhibitors with a Favorable Pharmacokinetic Profile and Anticancer In Vivo Efficacy.
Brindani N, Vuong LM, La Serra MA, Salvador N, Menichetti A, Acquistapace IM, Ortega JA, Veronesi M, Bertozzi SM, Summa M, Girotto S, Bertorelli R, Armirotti A, Ganesan AK, De Vivo M.
Brindani N, et al. Among authors: la serra ma.
J Med Chem. 2024 Jun 12. doi: 10.1021/acs.jmedchem.4c00855. Online ahead of print.
J Med Chem. 2024.
PMID: 38866385